Is there a role for SGLT2 inhibitors in patients with end-stage kidney disease?
Purpose of Review Chronic kidney disease and end-stage kidney disease (ESKD) are well-
established risk factors for cardiovascular disease (CVD), the leading cause of mortality in …
established risk factors for cardiovascular disease (CVD), the leading cause of mortality in …
Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update
M Sun, X Zhang, B Tan, Q Zhang, X Zhao… - Frontiers in …, 2024 - frontiersin.org
As a chemotherapy agent, doxorubicin is used to combat cancer. However, cardiotoxicity
has limited its use. The existing strategies fail to eliminate doxorubicin-induced …
has limited its use. The existing strategies fail to eliminate doxorubicin-induced …
Bibliometric and visual analysis of SGLT2 inhibitors in cardiovascular diseases
R Pan, Y He, W Melisandre, Y Zhang, W Su… - Frontiers in …, 2024 - frontiersin.org
Background Cardiovascular diseases (CVD) pose a significant threat to human health due
to their high mortality and morbidity rates. Despite advances in treatments, the prevalence …
to their high mortality and morbidity rates. Despite advances in treatments, the prevalence …
Endoplasmic reticulum stress in the pathogenesis of chemotherapy‐induced mucositis: Physiological mechanisms and therapeutic implications
F Heindryckx, M Sjöblom - Acta Physiologica, 2024 - Wiley Online Library
Chemotherapy is a common and effective treatment for cancer, but these drugs are also
associated with significant side effects affecting patients' well‐being. One such debilitating …
associated with significant side effects affecting patients' well‐being. One such debilitating …
[HTML][HTML] Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies
Sodium glucose cotransporter-2 inhibitors (SGLT2i), originally developed for type II diabetes
mellitus, have recently been approved for the treatment of heart failure in both diabetic and …
mellitus, have recently been approved for the treatment of heart failure in both diabetic and …